Global Retinal Biologics Industry Eyes an Impressive US$41.92 Billion Valuation by 2028, Fueled by Solid 11.1% CAGR | FMI Insights Reveals

The Global Retinal Biologics Industry is on the brink of a transformative journey, exhibiting remarkable growth with a projected value exceeding US$22.25 billion by 2022. This upward trajectory is set to surge even further, reaching a staggering US$41.92 billion by 2028, propelled by an impressive Compound Annual Growth Rate (CAGR) of 11.1% between 2022 and …

Global Retinal Biologics Industry Poised for an Impressive US$41.92 Billion Valuation by 2028, Driven by a Resilient 11.1% CAGR | According to FMI Insights

The Global Retinal Biologics Industry is undergoing a spectacular transformation, showcasing robust growth with an anticipated value exceeding US$22.25 billion by 2022. This upward trajectory is expected to continue, reaching a staggering US$41.92 billion by 2028, driven by an impressive Compound Annual Growth Rate (CAGR) of 11.1% between 2022 and 2028, according to recent insights …